News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
459,589 Results
Type
Article (28464)
Company Profile (74)
Press Release (431051)
Section
Business (144404)
Career Advice (1519)
Deals (24682)
Drug Delivery (51)
Drug Development (51743)
Employer Resources (102)
FDA (11357)
Job Trends (10438)
News (236185)
Policy (22026)
Tag
Academia (1756)
Alliances (40019)
Alzheimer's disease (921)
Approvals (11333)
Artificial intelligence (103)
Bankruptcy (221)
Best Places to Work (8593)
Breast cancer (95)
Cancer (829)
Cardiovascular disease (65)
Career advice (1288)
Cell therapy (164)
Clinical research (40327)
Collaboration (314)
Compensation (59)
COVID-19 (2465)
C-suite (63)
Data (865)
Diabetes (109)
Diagnostics (6149)
Earnings (60573)
Employer resources (91)
Events (66753)
Executive appointments (211)
FDA (11746)
Funding (252)
Gene therapy (125)
GLP-1 (377)
Government (3324)
Healthcare (12746)
Infectious disease (2548)
Inflammatory bowel disease (79)
Interviews (278)
IPO (11865)
Job creations (2176)
Job search strategy (1086)
Layoffs (242)
Legal (5171)
Lung cancer (124)
Manufacturing (131)
Medical device (8643)
Medtech (8647)
Mergers & acquisitions (12930)
Metabolic disorders (272)
Neuroscience (1109)
NextGen Class of 2024 (4217)
Non-profit (3006)
Northern California (996)
Obesity (149)
Opinion (147)
Patents (79)
People (35886)
Phase I (12501)
Phase II (17330)
Phase III (14053)
Pipeline (414)
Podcasts (56)
Postmarket research (1856)
Preclinical (5404)
Radiopharmaceuticals (211)
Rare diseases (146)
Real estate (3491)
Regulatory (14496)
Research institute (1683)
Resumes & cover letters (230)
Southern California (879)
Startups (2178)
United States (9499)
Vaccines (650)
Weight loss (105)
Date
Today (87)
Last 7 days (458)
Last 30 days (2590)
Last 365 days (25345)
2024 (23282)
2023 (28157)
2022 (36913)
2021 (40067)
2020 (38403)
2019 (31174)
2018 (23496)
2017 (22401)
2016 (21746)
2015 (25430)
2014 (20874)
2013 (18128)
2012 (18428)
2011 (18234)
2010 (17047)
Location
Africa (674)
Arizona (105)
Asia (26564)
Australia (4457)
California (2208)
Canada (894)
China (165)
Colorado (116)
Connecticut (123)
Europe (60966)
Florida (350)
Georgia (99)
Illinois (229)
Indiana (148)
Kansas (62)
Maryland (439)
Massachusetts (1711)
Michigan (126)
Minnesota (159)
New Jersey (757)
New York (736)
North Carolina (564)
Northern California (996)
Ohio (95)
Pennsylvania (582)
South America (854)
Southern California (879)
Texas (351)
Utah (74)
Washington State (247)
459,589 Results for "longhorn vaccines and diagnostics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Longhorn Vaccines and Diagnostics Composite Peptide Vaccine Combats Sepsis Related to Antimicrobial Resistant Tuberculosis
November 13, 2024
·
3 min read
Press Releases
Longhorn Vaccines and Diagnostics to Present Data on Antimicrobial Resistant Sepsis Vaccine LHNVD-303 at The Union World Conference on Lung Health 2024
November 7, 2024
·
3 min read
Press Releases
Longhorn Vaccines and Diagnostics Highlights New Data for LHNVD-303 its Bacterial Sepsis Vaccine at IDWeek 2024
October 17, 2024
·
3 min read
BioCapital
Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present three abstracts at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2024.
April 11, 2024
·
2 min read
Press Releases
Longhorn Vaccines and Diagnostics to Present Data on Universal Influenza Vaccine LHNVD-110 and Antimicrobial Resistant Sepsis Vaccine LHNVD-303 at IDWeek 2024
October 9, 2024
·
3 min read
BioCapital
Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024
Longhorn Vaccines and Diagnostics presented positive data from three key studies of its infectious disease franchise at the European Congress of Clinical Microbiology and Infectious Diseases 2024.
April 27, 2024
·
5 min read
BioCapital
Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses
Longhorn Vaccines and Diagnostics Congress all day April 2-4, 2024 on a mice study that examined LHNVD-110, a novel, unconjugated single peptide vaccine comprised of multiple epitopes to broadly target human and influenza viruses.
April 2, 2024
·
4 min read
BioCapital
Longhorn Vaccines and Diagnostics Presents Targeted Vaccine Approach for Mycobacterium Tuberculosis with LHNVD-301
Longhorn Vaccines and Diagnostics today presented new data from an animal study of LHNVD-301, the company’s lead tuberculosis vaccine candidate.
November 15, 2023
·
4 min read
BioCapital
New Study Shows Longhorn Vaccines and Diagnostics’ Universal Influenza Vaccine, LHNVD-105, Generates Broad and Durable Immune Responses in Animal Models
Longhorn Vaccines and Diagnostics LLC, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, announced today new data supporting the potential benefits of LHNVD-105, the company’s universal influenza vaccine candidate.
September 27, 2023
·
3 min read
BioCapital
Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, will present new data from an animal study of LHNVD-301, the company’s tuberculosis vaccine candidate, at The Union World Conference on Lung Health 2023.
November 2, 2023
·
2 min read
1 of 45,959
Next
